View More
In this CME-certified interactive presentation, Kathleen Mullane, DO, PharmD, provides expert perspectives on optimal strategies for preventing and managing CMV infection in patients undergoing bone marrow transplantation.
Kathleen Mullane, DO, PharmD
Physicians:
maximum of 1.0 AMA PRA Category 1 Credit™
Released: December 13, 2017
Expired: December 12, 2018
In this downloadable slideset, Kathleen Mullane, DO, PharmD, provides expert perspectives on current and emerging strategies for preventing and managing CMV infection in patients undergoing bone marrow transplantation.
How might emerging investigational agents change the management of CMV infection in the post–hematopoietic cell transplantation setting? Here’s my take.
Roy F. Chemaly, MD
Released: September 6, 2017
How has the approval of letermovir prophylaxis altered post-HCT CMV management? Here’s my take.
Genovefa A. Papanicolaou, MD
Released: January 16, 2018
Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112
Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.